Xian Weng Jiang

Xian Weng Jiang has a diverse work experience in the field of biology and bioengineering. In 2019, Xian served as the Head of Biology at Mytos, where they led and managed all aspects related to biology, including planning and executing multidisciplinary projects. They also created and expanded departments within the company.

Prior to their role at Mytos, Xian worked at Orphidia, Inc. from 2017 to 2019. During this time, they held positions such as Principal Scientist and Senior Scientist. Xian provided scientific leadership within the biology team, focusing on surface functionalization and biomolecule immobilization. They also contributed to bioanalytical method development and assay development.

In 2017, Xian worked at Lonza as a Senior Scientist. In this role, they acted as a study director in the Method Development and Validation team. They conducted complex analytical experiments, managed cross-functional projects, and ensured compliance with current GMP guidelines.

Xian's experience also includes a role as a Formulation Scientist at Nanomerics Ltd and UCL in 2016-2017. They were involved in the formulation, stability testing, and pharmacokinetics of orally delivered peptides using nanoparticles. Xian synthesized nanoparticles, formulated peptides, and characterized nanoparticles.

Furthermore, Xian worked as a PhD student and a postgraduate student at University College London from 2012 to 2016. They focused on the production and characterization of iron oxide nanoparticles for breast cancer theranostics. Xian also obtained an MSc in Nanotechnology and Regenerative Medicine, specializing in biomaterials and tissue engineering.

Xian's previous experience includes collaborating with CEA - Commissariat à lénergie atomique et aux énergies alternatives on the coupling of breast cancer targeting aptamers to iron oxide nanoparticles. They also interned at Universitat Pompeu Fabra.

Overall, Xian Weng Jiang has a strong background in biology, bioengineering, and nanotechnology, with a track record of leadership and technical expertise in various scientific roles.

Xian Weng Jiang pursued their education in a systematic manner, starting with a Bachelor of Science (BSc) Hons degree in Human Biology from Universitat Pompeu Fabra, which they completed between 2008 and 2012. Building upon this foundation, they went on to pursue a Master of Science (MSc) in Nanotechnology and regenerative medicine from University College London, U. of London, from 2012 to 2013. Xian then proceeded to further expand their knowledge and expertise by enrolling in the UCL School of Pharmacy, where they completed a Doctor of Philosophy (PhD) degree in Nanomedicine between 2013 and 2016. This comprehensive educational journey showcases Xian Weng Jiang's dedication to learning and specialization within the field of nanomedicine.